CN117903983A - Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation - Google Patents
Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation Download PDFInfo
- Publication number
- CN117903983A CN117903983A CN202410043166.5A CN202410043166A CN117903983A CN 117903983 A CN117903983 A CN 117903983A CN 202410043166 A CN202410043166 A CN 202410043166A CN 117903983 A CN117903983 A CN 117903983A
- Authority
- CN
- China
- Prior art keywords
- concentration
- fermentation
- acid
- arginine
- corynebacterium glutamicum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 105
- 230000004151 fermentation Effects 0.000 title claims abstract description 105
- 241000186226 Corynebacterium glutamicum Species 0.000 title claims abstract description 43
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title claims abstract description 29
- 229930064664 L-arginine Natural products 0.000 title claims abstract description 29
- 235000014852 L-arginine Nutrition 0.000 title claims abstract description 29
- 239000002068 microbial inoculum Substances 0.000 title abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 22
- 238000009423 ventilation Methods 0.000 claims description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 17
- 239000008103 glucose Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 12
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 12
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 235000013379 molasses Nutrition 0.000 claims description 8
- 241001052560 Thallis Species 0.000 claims description 7
- 239000006052 feed supplement Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 239000002253 acid Substances 0.000 abstract description 156
- 238000006243 chemical reaction Methods 0.000 abstract description 36
- 239000004475 Arginine Substances 0.000 abstract description 29
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 29
- 235000009697 arginine Nutrition 0.000 abstract description 29
- 230000001580 bacterial effect Effects 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 description 66
- 230000001965 increasing effect Effects 0.000 description 27
- 239000002609 medium Substances 0.000 description 21
- 239000007789 gas Substances 0.000 description 20
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 19
- 125000005842 heteroatom Chemical group 0.000 description 19
- 239000001301 oxygen Substances 0.000 description 19
- 229910052760 oxygen Inorganic materials 0.000 description 19
- 230000008569 process Effects 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 230000001276 controlling effect Effects 0.000 description 12
- 231100000350 mutagenesis Toxicity 0.000 description 12
- 238000002703 mutagenesis Methods 0.000 description 11
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 5
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- BRBKOPJOKNSWSG-UHFFFAOYSA-N sulfaguanidine Chemical compound NC(=N)NS(=O)(=O)C1=CC=C(N)C=C1 BRBKOPJOKNSWSG-UHFFFAOYSA-N 0.000 description 5
- 229960004257 sulfaguanidine Drugs 0.000 description 5
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000004868 gas analysis Methods 0.000 description 4
- 229930028154 D-arginine Natural products 0.000 description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 229960002173 citrulline Drugs 0.000 description 3
- 235000013477 citrulline Nutrition 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 3
- 229940008406 diethyl sulfate Drugs 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012803 optimization experiment Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- IXHTVNGQTIZAFS-BYPYZUCNSA-N L-arginine hydroxamate Chemical compound ONC(=O)[C@@H](N)CCCN=C(N)N IXHTVNGQTIZAFS-BYPYZUCNSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a corynebacterium glutamicum mutant strain, a microbial inoculum thereof and application thereof in L-arginine fermentation; the mutant strain has the characteristics of high L-arginine yield and low mixed acid, and the invention also comprises a bacterial agent containing the mutant strain and application thereof in L-arginine fermentation. In the fermentation process, according to the thallus concentration OD 562, a method for controlling the concentration of CO 2 in fermentation tail gas in stages is adopted, so that the arginine yield and the sugar acid conversion rate are obviously improved. The fermentation method has high acid yield, less mixed acid, 12.5% of arginine yield, 52.3% of sugar acid conversion rate and 0.4% of mixed acid total amount; compared with the method for calculating OUR, CER and RQ values to perform fermentation control, the method for controlling the concentration of CO 2 is quicker and more practical, can more accurately judge the strain state, is an efficient and practical L-arginine fermentation process, and has remarkable industrial application value.
Description
Technical Field
The invention relates to the technical field of fermentation engineering, in particular to a corynebacterium glutamicum mutant strain, a microbial inoculum thereof and application of the corynebacterium glutamicum mutant strain in L-arginine fermentation.
Background
The L-arginine system is named as 2-amino-5-guanidyl valeric acid, is a semi-essential amino acid in human body, can improve nitrogen metabolism balance in human body, and can be used as an antidote for treating ammonia poisoning hepatic coma, so that arginine is very important for maintaining liver health, and medical research proves that arginine has obvious effects in enhancing human body immunity and delaying aging.
The production methods of L-arginine mainly include chemical catalysis, proteolysis and microbial fermentation, wherein microbial fermentation is the main method for producing L-arginine. Corynebacterium glutamicum is a gram-positive bacterium as a main fungus for producing L-arginine, accords with food production safety, and can be used for producing glutamic acid by industrial fermentation.
The following are some patents listing the related art of arginine fermentation and tail gas analysis, and it can be seen that the main hot spots and processes in the amino acid fermentation field in the prior art are as follows:
A process for producing arginine by fermenting fed-batch culture solution comprises CN 112430633A: the patent discloses a process for fermenting arginine by using a fed-batch culture solution, wherein arginine is produced by feeding an ammonium sulfate aqueous solution and a glucose solution in the fermentation process;
Escherichia coli and application thereof in fermentation production of L-arginine, CN 116355814A: the patent discloses an escherichia coli which is cultured in the mode, a 30L fermentation tank is adopted for culturing, fermentation culture is carried out for 48 hours, the yield of L-arginine is 136.65g/L, and the conversion rate is 48.58%. Culture medium: comprises 1g/L glucose, 1g/L yeast powder, 1g/L ammonium sulfate, 1g/L monopotassium phosphate, 0.5g/L magnesium sulfate, 0.01g/L manganese sulfate and 0.01g/L zinc sulfate;
The technology for improving the fermentation and acid production of L-arginine is disclosed as CN 10540626A: the patent discloses that the Brevibacterium flavum obtains high acid production capacity through mutagenesis, trend control is adopted in the fermentation process, and the final acid production capacity of strict feed supplement reaches 3-4%;
A biological method for producing adenosylmethionine based on an exhaust gas analysis system comprises the steps of CN 115927516A: the patent discloses a method for producing adenosylmethionine based on a tail gas analysis system biological method. The production method is a method for promoting the yield of S-adenosylmethionine by regulating and controlling cell metabolism at the cellular level through a physiological metabolism parameter RQ based on a fermentation tail gas analysis system.
At present, the domestic fermentation method of amino acids such as arginine generally adopts a mode of controlling dissolved oxygen and the like, although the method can achieve the process aim to a certain extent, as the dissolved oxygen electrode is influenced by various conditions in fermentation liquor, the dissolved oxygen electrode is interfered in detection accuracy, and when parameters such as OUR, CER, RQ values and the like are adopted for fermentation control, the error becomes larger due to excessive calculation formulas, and the method is not suitable for common fermentation workshop operation, so the patent develops a control method which can replace the dissolved oxygen control process, utilizes the correlation of bacterial liquid concentration and fermentation tail gas CO 2 concentration, solves the control difficulty, increases the arginine yield and the sugar acid conversion rate, and reduces the impurity acid yield.
Disclosure of Invention
Aiming at the defects in the prior art, the invention discloses a corynebacterium glutamicum mutant strain, a microbial inoculum thereof and application thereof in L-arginine fermentation. The invention obtains a high-yield strain through mutagenesis, and in the process of technological development, the concentration of CO 2 in the fermentation tail gas is controlled in a gradient manner, so that a process with high acid yield, high sugar acid conversion rate and low mixed acid is obtained, and the problem of low acid production efficiency in the prior art is solved.
Firstly, the mutant strain of the corynebacterium glutamicum is corynebacterium glutamicum IBBZ-01
(Corynebacterium glutamicum) the preservation number is CCTCC NO: M2022765; the preservation unit is China center for type culture Collection, and the address is Wu Changou eight paths of Wuhan City in Hubei province, and Wuhan university; the zip code 430072; the preservation date is 2022, 05 and 30.
Furthermore, the corynebacterium glutamicum IBBZ-01 (Corynebacterium glutamicum) is a production strain with high yield of L-arginine and less side acid, which is screened out by taking corynebacterium glutamicum (CICC No. 20160) as an initial strain and performing induced mutation and directional culture.
The invention provides a microbial inoculum containing the corynebacterium glutamicum IBBZ-01 (Corynebacterium glutamicum), which comprises the following components: the flora of Corynebacterium glutamicum IBBZ-01 (Corynebacterium glutamicum), and/or cultures thereof, and/or extracts thereof.
In another aspect, the application also discloses an application of the corynebacterium glutamicum IBBZ-01 in L-arginine fermentation;
With respect to the technical scheme, it is further preferred that in the application, the method for fermenting L-arginine comprises the step of controlling the concentration of CO 2 in the fermentation tail gas in stages according to the condition of the strain concentration OD 562. Thereby greatly improving the yield of arginine;
With respect to the technical solution described above, it is further preferred that the fermentation method comprises the steps of:
(1) In the fermentation process, when the concentration OD 562 of the thallus is 10-20, the concentration of CO 2 is controlled to be 0.5-1.5%;
(2) When the strain concentration OD 562 is 20-30, controlling the concentration of CO 2 to be 2.0-3.5%;
(3) In the fermentation process, if the residual sugar is reduced to 0.5-1.5%, feeding a feed supplement sugar solution, wherein the residual sugar is controlled to be 0.5-1.5%;
(4) When the concentration OD 562 of the thalli is 30-40, controlling the concentration of CO 2 to be 4.0-5.0%;
(5) When the concentration OD 562 of the fermentation liquid to be detected is larger than 40, the concentration of CO 2 is controlled to be 5.5-6.5%.
For the technical scheme, the feeding sugar solution is preferably 50-80 wt% of glucose solution.
For the above technical solution, it is further preferable that the fermentation conditions are controlled in the initial stage of the fermentation process in the step (1): ventilation is 90-120 LPM, temperature is 29-33 ℃, pH is 7-7.3. Still more preferably, the fermentation conditions are aeration rate of 100LPM, temperature of 31℃and pH 7.0;
For the above technical solution, it is further preferred that the concentration range of the CO 2 in the step (1) is 0.8-1.2%, the concentration range of the CO 2 in the step (2) is 2.5-3.0%, the concentration range of the CO 2 in the step (4) is 4.3-4.7%, and the concentration range of the CO 2 in the step (5) is 5.8-6.2%.
For the above technical solution, it is further preferable that in the step, the control change of the concentration of CO 2 can be controlled according to the OD 562 value of the concentration of the bacterial cells. In addition, although detecting the dissolved oxygen value is one possible control means, it is not necessary. In practice, we can achieve control of carbon dioxide concentration by adjusting the rotational speed. This control is entirely dependent on the concentration of CO 2 in the fermentation tail gas. Typically, the rotational speed is set to 200 to 450rpm. In this way, the concentration of CO 2 can be regulated by means of the concentration of the thallus, the fermentation process can be flexibly managed by the rotation speed regulation, and the monitoring of the dissolved oxygen value is used as an optional control means.
For the technical scheme, further, the culture medium in the process of expanding the inoculation volume step by step of the L-arginine producing strain IBBZ-01 in the step (1) comprises:
Primary seed medium: 3 to 5 weight percent of glucose, 1.0 to 1.2 weight percent of corn steep liquor dry powder, 1.0 to 1.5 weight percent of molasses, 0.3 to 0.5 weight percent of ammonium sulfate, 0.05 to 0.07 weight percent of KH 2PO4 0.1~0.13wt%,MgSO4·7H2 O, 0.5 to 1.0 weight percent of calcium carbonate and 7.0 to 7.2 weight percent of pH 7;
Secondary seed medium: 3 to 5 weight percent of glucose, 1.0 to 1.2 weight percent of corn steep liquor dry powder, 1.0 to 1.5 weight percent of molasses, 0.3 to 0.5 weight percent of ammonium sulfate, 0.05 to 0.07 weight percent of KH 2PO4 0.1~0.13wt%,MgSO4·7H2 O and pH of 6.8 to 7.2;
Fermentation initial medium: 6 to 8 weight percent of glucose, 1.0 to 1.3 weight percent of corn steep liquor dry powder, 2.0 to 2.4 weight percent of molasses, 0.01 to 0.05 weight percent of yeast powder, 0.3 to 0.5 weight percent of ammonium sulfate and 0.05 to 0.07 weight percent of KH 2PO4 0.1~0.13wt%,MgSO4·7H2 O.
Compared with the prior art, the invention has the following beneficial effects:
1. According to the invention, a strain with high L-arginine yield is obtained through screening and optimization, the acid yield is high, the detection result in the example 1 with less mixed acid reaches 12.5% of arginine yield, the sugar-acid conversion rate is 52.3%, and the total amount of mixed acid such as citrulline, ornithine and the like is 0.4%; as is clear from comparative example 6, corynebacterium glutamicum IBBZ-01 of the present invention had a 3-fold increase in arginine production compared to its starting strain Corynebacterium glutamicum CICC No.20160 and a 3.37-fold increase in sugar acid conversion compared to its starting strain. The production of the hetero acid is obviously reduced, and the hetero acid amount of the corynebacterium glutamicum IBBZ-01 is reduced to 26% of that of the original strain, which shows that the fermentation performance is obviously improved;
2. In the process of synthesizing arginine by microorganisms, the concentration of CO 2 in fermentation tail gas directly reflects the growth, propagation and metabolism states of the strain, especially reflects the strength of aerobic and anaerobic metabolic processes of the strain, can obviously reduce the difficulty of fermentation control by combining the control mode of fermentation tail gas and metabolic processes, and can ensure that the acid production of arginine reaches about 12% at most and the sugar acid conversion rate reaches more than 50%;
3. According to the method, the concentration OD 562 of the thalli is closely related to the concentration of CO 2 in the fermentation tail gas, and then the concentration of CO 2 is controlled in stages, so that the method can better regulate the metabolic activity of the thalli according to different characteristics of each stage of the production bacteria, obviously improve the acid production and sugar acid conversion rate of arginine and reduce the mixed acid;
4. the invention replaces the conventional fermentation mode of dissolved oxygen control by controlling the concentration of the fermentation tail gas CO 2, and has the characteristics of higher accuracy, higher practicability and the like by controlling the concentration of CO 2 compared with the dissolved oxygen control;
5. At present, the detection of fermentation tail gas is gradually started to be applied to fermentation process development, the OUR, CER and RQ values are generally calculated to perform fermentation control, and the main direction of fermentation metabolic flow is judged, and in the method, only the way of controlling the concentration of CO 2 is adopted.
Detailed Description
The present invention will be further described with reference to examples, but it should be understood that the scope of the present invention is not limited by the examples.
In the present invention, percentages and percentages are by mass unless explicitly stated otherwise. Unless otherwise specified, all experimental procedures used are conventional and all materials, reagents, etc. used are commercially available.
L-arginine and less by-product strain IBBZ-01 deposited in China center for type culture Collection, at a site of 2022, month 05, 30: china, university of Wuhan, and preservation number is CCTCC NO: M2022765.
Characteristics of Corynebacterium glutamicum:
The corynebacterium glutamicum (Corynebacterium glutamicum) IBBZ-01 (CCTCC NO: M2022765) which is a high-yield L-arginine production strain is obtained by taking the corynebacterium glutamicum (CICC No. 20160) of L-arginine as an initial strain and screening the initial strain through mutagenesis; genetic markers: sulfaguanidine (SG) resistance, arginine hydroxamic acid resistance, D-Arg resistance, L-homoarginine (L-HA) resistance;
the composition of the culture medium is as follows:
Complete Medium (CM): 1.0wt% of glucose, 1wt% of beef extract, 0.5wt% of peptone, 0.5wt% of yeast extract, 0.5wt% of sodium chloride, 0.5wt% of urea and pH 7.0-7.2;
minimal Medium (MM): glucose 3wt%, ammonium sulfate 0.5wt%, KH 2PO4 0.1wt%,MgSO4·7H2 O0.05 wt%, pH 7.0-7.2;
Supplemented Medium (SM): adding a structural analogue of an amino acid to a Minimal Medium (MM), pH 7.0-7.2; structural analogues of amino acids include sulfaguanidine, homoarginine, D-arginine;
Seed culture medium: 3wt% of glucose, 1.0wt% of corn steep liquor dry powder, 1.0wt% of molasses, 0.3wt% of ammonium sulfate, 0.05wt% of KH 2PO4 0.1wt%,MgSO4·7H2 O, 0.5wt% of calcium carbonate and pH 7.0-7.2;
Shake flask fermentation medium: 10wt% of glucose, 1.1wt% of corn steep liquor dry powder, 1wt% of ammonium sulfate, 0.05wt% of KH 2PO40.1wt%,MgSO4·7H2 O and 1wt% of calcium carbonate;
the breeding process is as follows:
(1) Pretreatment of mutagenesis:
a ring of activated strain is inoculated into a conical flask filled with 25mL of liquid complete medium, and placed in a reciprocating shaker at 30 ℃ and 85rpm for shaking culture for 12h. Then 1mL of culture solution is taken and is connected into another conical flask containing 25mL of liquid complete culture medium, and the conical flask is placed in a reciprocating shaking table at 30 ℃ and 90rpm to oscillate for 4 hours, so that cells are in logarithmic growth phase.
(2) Preparation of bacterial suspension:
10mL of culture solution is taken in a sterile centrifuge tube, centrifuged at 5000rpm for 10min, the supernatant is discarded, cells are resuspended by adopting physiological saline and then poured into a conical flask, the shaking is carried out for 10min, and the cell concentration is adjusted to 5X 10 8 cells/mL.
(3) Ultraviolet mutagenesis:
And (3) taking the prepared bacterial suspension, carrying out mutagenesis on the bacterial suspension for a certain time under ultraviolet light, sampling, diluting, coating and culturing the bacterial suspension on a flat plate, and calculating the mortality rate. And (3) eliminating the wild type and concentrated defect by adopting starvation culture and penicillin method, detecting the defect by using an audio-visual culture method, and verifying the acid production capacity of fermentation.
(4) Diethyl sulfate mutagenesis:
Adding 0.5wt% diethyl sulfate (DES) into the prepared bacterial suspension, oscillating at 30 ℃ for 20min, stopping treatment, coating on a screening culture medium SM flat plate, and standing at 31 ℃ for 4-6 days. The single colony of the mutant strain growing on SM is selected and transferred to MM plates added with sulfaguanidine, homoarginine and D-arginine respectively, and the mutant strain is subjected to static culture at 31 ℃ for 24 hours and then enters a shaking bottle for rescreening.
(5) Art mutagenesis:
A proper amount of bacterial suspension is absorbed and uniformly coated on a sterile metal slide, and the sterile metal slide is placed in a mutagenesis room of an ARTP biological mutagenesis breeding machine with helium as working gas, power of a power supply of 100W, working gas flow of 10L/min and treatment distance of 2mm, and mutagenesis treatment is carried out for 0, 20, 30, 60 and 120 seconds respectively; after stopping the treatment, the cells are spread on a screening medium SM plate and are subjected to static culture at 31 ℃ for 4 to 6 days. Selecting single colony of mutant strain growing on SM, transferring to MM plate added with sulfaguanidine, homoarginine and D-arginine respectively, standing at 31deg.C for 24 hr, and shaking for re-screening;
(6) Shaking and re-screening:
Inoculating the mutant strain to shake flask fermentation medium, shake culturing at 31deg.C and 110rpm for 72 hr, and detecting accumulated L-arginine in the mutant strain fermentation broth by high performance liquid phase method, wherein the strain producing highest L-leucine in all mutants is IBBZ-01.
(7) The shake flask culture process comprises the following steps:
Preparing shake flask seed liquid: inoculating a corynebacterium polyglutamic acid mutant strain IBBZ-01 into a seed culture medium, and culturing for 16 hours at 30 ℃ and 90rpm, wherein the bacterial concentration OD 562 is about 0.5-0.6 x 20 for later use;
shake flask seeds were inoculated into a shake flask fermentation medium at 8% (V/V), cultured at 30℃for 72 hours at 120rpm, and the L-arginine production was examined by high performance liquid chromatography, with the yield of original strain CICC No.20160 being 4.5g/L, and the yield of mutant strain IBBZ-01 being 34.2g/L, and the mutant strain was found to have a stronger acid-producing ability and more excellent L-arginine-producing ability than the original strain.
Example 1
1. The seed medium consisted of:
primary seed medium:
3wt% of glucose, 1.0wt% of corn steep liquor dry powder, 1.0wt% of molasses, 0.3wt% of ammonium sulfate, 0.05wt% of KH 2PO40.1wt%,MgSO4·7H2 O and 1.0wt% of calcium carbonate; split charging 500 ml/3000 ml; sterilizing at 121 ℃/20min;
secondary seed pot medium:
3wt% of glucose, 1.0wt% of corn steep liquor dry powder, 1.0wt% of molasses, 0.3wt% of ammonium sulfate, 0.05wt% of KH 2PO40.1wt%,MgSO4·7H2 O, pH 7.0-7.2 and sterilization conditions of 121 ℃/20min;
2. The fermentation medium was as follows:
Standard fermenter fermentation initial medium: 7wt% of glucose, 1.0wt% of corn steep liquor dry powder, 2.0wt% of molasses, 0.01 wt% of yeast powder, 0.3wt% of ammonium sulfate and 0.05wt% of KH 2PO4 0.1wt%,MgSO4·7H2 O
Feed supplement sugar solution: 60wt% glucose;
3. Fermentation tank process
Step 1:
Inoculating corynebacterium glutamicum IBBZ-01 into a primary seed culture medium of a shake flask, and performing shake culture at 30 ℃ and 90rpm for 16 hours to obtain 500mL of shake flask seed liquid, wherein the primary seed liquid is a maturation mark: OD 562 is 0.5-0.6 x 20.
Step 2:
Inoculating the shake flask seed liquid into a 50L secondary seed tank culture medium at a ratio of 0.3% (V/V), wherein the pH is 6.8 at 30 ℃, the dissolved oxygen is not less than 20%, and culturing for 16h, wherein the secondary seed liquid is mature as a sign: OD 562 is 0.5-0.6x20; obtaining a secondary seed liquid;
step 3:
1) 10% of secondary seed liquid is inoculated into a 500L fermentation tank, the initial fermentation liquid loading amount is 60%, the fermentation temperature is 31 ℃, the pH value is 7.0, the rotating speed is 200RPM, the ventilation amount is 100LPM, the tank pressure is 0.05Mpa, the concentration of fermentation tail gas CO 2 is used as a main control standard in the process, dissolved oxygen is not monitored and controlled any more, and the OD 562 does not need to be adjusted in the process of 1-10 after inoculation;
2) When the concentration OD 562 of the thalli grows to between 10 and 20, the concentration of CO 2 is controlled to be 0.9 percent by adjusting the rotating speed;
3) When the strain concentration OD 562 is 20-30, controlling the concentration of CO 2 to 2.8% through the rotating speed;
4) When the residual sugar is reduced to 0.8wt%, feeding of the feed supplement sugar solution is started, and the residual sugar is controlled to be about 0.8 wt%.
5) When the strain concentration OD 562 is 30-40, the concentration of CO 2 is controlled to be 4.5% by adjusting the rotating speed;
6) After the concentration OD 562 of the detected thalli is more than 40, controlling the concentration of CO 2 to be 6.0% by adjusting the rotating speed;
7) The sugar liquor is fed completely and the residual sugar is exhausted, and the tank is put down, the arginine yield is 12.5wt%, the sugar acid conversion rate is 52.3%, and the total amount of the mixed acid such as citrulline, ornithine and the like is 0.4wt%.
As shown in example 1, the core of the process is to perform arginine fermentation in a mode of controlling the concentration of CO 2 in fermentation tail gas according to the growth trend of the production microbial inoculum, and the mode is abandoned according to the original dissolved oxygen control mode; according to the control mode, the acid production and conversion rate of arginine are obviously improved, and the mixed acid is obviously reduced;
During the fermentation process, the acid production refers to the actual concentration of arginine in the fermentation broth. The sugar acid conversion was calculated as follows:
Sugar acid conversion = (actual arginine concentration x actual fermentation volume)/(actual glucose consumption total x 100%)
Meanwhile, the hetero acid refers to the sum of the concentration of citrulline and ornithine in the fermentation broth. These two parameters are used together to evaluate the efficiency and product composition of the fermentation process.
Example 2 (different CO 2 control concentration ranges)
Based on example 1: in the step 3, the concentration of CO 2 in the fermentation tail gas is respectively controlled in different ranges; the method and results are shown in Table 1:
TABLE 1 gradient control ranges for different concentrations of CO 2
As shown in the table results, the key steps are the most in gradient control of CO 2 concentration according to the cell concentration OD 562: OD 562 is 10-20, and the concentration of CO 2 is controlled to be 0.5-1.5%; OD 562 is in the stage of 20-30, and the concentration of CO 2 needs to be controlled at 2.0-3.5%; OD 562 is controlled at 30-40 stage, CO 2 concentration is controlled to be 4.0-5.0%, OD 562 is controlled to be more than 40, CO 2 concentration is controlled to be 5.5-6.5%, and too low or too high CO 2 concentration can lead to reduced acid production and increased hetero acid.
Acid production: it can be seen that the control of the CO 2 concentration stage is close to example 1, the higher the acid production, the lower the acid production, the larger the deviation.
Hybrid acid: also closely related to the CO 2 concentration stage control, the more deviate from example 1, the higher its hetero-acid;
As shown in the data of the group 1-3, the data of the group are subjected to an optimization experiment that the concentration of CO 2 is controlled to be 0.5-1.5% when the concentration of the bacterial cells OD 562 -20, and the result shows that the acid production and the sugar acid ratio of the CO 2 are in a trend of increasing firstly and then decreasing as the concentration of the CO 2 is increased, the mixed acid is decreased firstly and then increased, and the concentration of the CO 2 is higher as the concentration of the CO 2 is close to 0.9% in the embodiment 1, so that the result is better.
As shown in the data of the group 4-6, the optimized experiment that the concentration of CO 2 is controlled to be 2.0-3.5% when the concentration of the bacteria OD 562 -30 is carried out in the data of the group, and similarly, as the concentration of CO 2 is increased, the acid production and the sugar acid ratio of the bacteria are in a trend of increasing firstly and then decreasing, the mixed acid is decreased firstly and then increased, and the concentration of CO 2 is higher as the concentration is closer to 2.8% in the embodiment 1, the acid production and the sugar acid conversion rate is higher, and the mixed acid is lower.
As shown in the data of the group 7-9, the optimized experiment that the concentration of CO 2 is controlled to be 4.0-5.0% when the concentration of the bacteria OD 562 -40 is carried out in the data of the group, as the concentration of CO 2 is increased, the acid production ratio and the sugar acid ratio of the bacteria are increased firstly and then reduced, the mixed acid is reduced firstly and then increased, and the closer the concentration of CO 2 is to 4.5% in the embodiment 1, the acid production and the sugar acid conversion rate are higher, and the mixed acid is lower.
As shown in the data of the group 10-12, the optimized experiment that the concentration of CO 2 is controlled to be 5.5-6.5% when the concentration of the bacteria is over OD 562 and the concentration of the acid and the sugar acid are increased and then reduced along with the increase of the concentration of CO 2, the mixed acid is reduced and then increased, and the concentration of CO 2 is closer to 6.0% in the embodiment 1, the acid and the sugar acid are converted more and the mixed acid is reduced.
Conclusion: experiments prove that the concentration of CO 2 is controlled by gradient, so that the acid production and the sugar acid conversion rate can be improved and promoted, and the synthesis of the mixed acid can be inhibited.
Example 3 (different ventilation)
Based on example 1, the ventilation in step 3 was controlled to be performed under different conditions, and the results are shown in table 2:
TABLE 2 different ventilation
Sequence number | Ventilation LPM | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 90 | 10.8 | 47.0 | 0.6 |
2 | 95 | 11.8 | 51.3 | 0.5 |
3 | 105 | 11.5 | 50.0 | 0.4 |
4 | 115 | 10.5 | 45.7 | 0.8 |
5 | 120 | 10.2 | 44.3 | 0.9 |
As shown in data 1-5, ventilation optimization experiments were performed, and the results showed that: in the range of 90-120 LPM, the acid production and sugar acid conversion rate show a trend of increasing and then decreasing with increasing ventilation, wherein 95LPM has the best effect, and the mixed acid shows a trend of decreasing and then increasing, and the mixed acid is the lowest at 105 LPM.
The amount of ventilation determines how much oxygen it enters the fermenter, thereby affecting the oxygen transfer coefficient, resulting in changes in bacterial strain respiratory metabolism, and affecting the ability of the rotational speed to control the concentration of fermentation tail gas CO 2.
On the premise that the rate of CO 2 generated by thalli in the acid production period, namely CER, is stable, increasing ventilation volume can generate the effect of diluting the concentration of CO 2 in fermentation tail gas, so that the gradient control range of CO 2 is narrowed, and the gradient control of CO 2 in each stage cannot be distinguished, thereby causing experimental failure; decreasing ventilation can lead to a sudden increase in the concentration of CO 2 during the early stages of fermentation, or too sensitive when the CO 2 concentration is controlled at a slightly elevated speed, resulting in a steep increase in the concentration of CO 2, which can adversely affect process stability.
In summary, in controlling the concentration of CO 2, the range of ventilation needs to be strictly controlled, so that the concentration of CO 2 in the whole process is in a stable and controllable state.
Example 4 (different fermentation temperatures and pH)
Based on example 1: the fermentation temperature and pH in step 3 were controlled to different conditions, and the results are shown in Table 3 below:
TABLE 3 different temperatures and pH
Acid yield: the 4 groups of acid production are respectively about 11%, and compared with the example 1, the acid production is reduced to some extent, and the temperature and the pH are proved to have a certain influence on the acid production.
Sugar acid conversion: has an effect and slightly drops.
Hybrid acid: is not affected.
Combining the above data analysis, it can be concluded that: the change of temperature and pH has a certain influence on the acid production and the conversion rate of the sugar acid, but has a small influence on the mixed acid;
example 5 (control of different residual sugar concentrations)
Based on example 1: the fermentation residual sugar concentration in the step 3 is controlled under different conditions, and the results are shown in the following table 4:
TABLE 4 different residual sugar concentrations
Sequence number | Residual sugar wt% | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 0.5 | 11.4 | 49.57 | 0.4 |
2 | 1.0 | 11.9 | 51.74 | 0.5 |
3 | 1.5 | 10.9 | 47.39 | 0.5 |
Acid production: reducing or increasing the residual sugar control concentration had some effect on acid production, and from the 3-group results, the residual sugar deviation resulted in some fluctuation in acid production compared to the 0.8% concentration control in example 1.
Sugar acid conversion: consistent with the acid production trend, the sugar acid conversion rate is reduced to different degrees.
Hybrid acid: is not affected.
Combining the above data analysis, it can be concluded that: the control range of residual sugar ranging from 0.5 to 1.5wt% has a certain effect on both acid production and sugar acid conversion, but less on the hetero acid.
Comparative example 1 (comparative example 1)
Based on example 1, the control method of step 3 was adopted to perform fermentation by using a dissolved oxygen control method, and the dissolved oxygen was controlled to be 5-25%, and the results are shown in the following table 5:
TABLE 5 control with different dissolved oxygen
Sequence number | Dissolved oxygen% | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 5 | 5.6 | 24.35 | 3.5 |
2 | 15 | 8.5 | 36.96 | 1.9 |
3 | 25 | 7.2 | 31.30 | 2.5 |
As shown in the current 3 groups of results, the maximum acid production rate of a 15% dissolved oxygen control mode is 8.5wt%, the other two conditions are 5.6wt% and 7.2wt%, the sugar-acid conversion rate is lower, the maximum sugar-acid conversion rate is about 37%, the maximum acid production rate cannot reach the level of the example 1, and the mixed acid is far higher than 0.4wt%.
Combining the above data analysis, it can be concluded that: the fermentation by the dissolved oxygen control method cannot reach the fermentation result of the gradient control of the concentration of the fermentation tail gas CO 2 in the embodiment 1, and the adoption of the gradient control of the concentration of the CO 2 for arginine fermentation has the advantages of obviously improving the acid production and the sugar acid conversion rate and reducing the mixed acid.
Comparative example 2 (comparative example 2)
Based on example 2, the control range of the fermentation tail gas CO 2 in step 3 was modified, and the results are shown in Table 6:
TABLE 6 different CO 2 control ranges
As seen from the current 8 groups of results, the concentration of CO 2 in the gradient control fermentation tail gas needs to be strictly regulated according to the concentration OD 562, and too high or too low concentration of CO 2 in each stage can reduce the ratio of acid production to sugar acid, and even increase the content of mixed acid.
1. The 2 groups of experimental data show that the acid production and sugar acid conversion rate can be reduced, but the increase of the mixed acid is not obvious if the concentration of CO 2 is controlled to be outside 0.5-1.5% in the range of the cell concentration OD 562 -20.
The 3-8 sets of experimental data indicate that the concentration OD 562 at each stage needs to be controlled within the range expressed in example 2, beyond which it results in reduced acid production and sugar acid conversion, and in increased hetero acids.
Comparative example 2 thus demonstrates that fermentation tail gas CO 2 concentration gradient control needs to be performed as in example 2.
Comparative example 3 (comparative example 3)
Based on example 3, the ventilation range in step 3 was further reduced or increased, resulting in the following table 7:
TABLE 7 different ventilation
Sequence number | Ventilation LPM | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 70 | 8.5 | 36.96 | 1.2 |
2 | 80 | 9.5 | 41.30 | 0.8 |
3 | 130 | 9.6 | 41.74 | 1.0 |
4 | 140 | 9.4 | 40.87 | 1.5 |
According to the current 4 groups of experimental results, with the increase or decrease of ventilation, the method has obvious influence on acid production and sugar acid conversion rate and mixed acid;
from the point of view of acid production and sugar acid conversion, outside the range specified in example 3, lower aeration levels will result in lower acid production and sugar acid conversion, increased hetero acids, and similarly higher aeration levels will also result in lower acid production and sugar acid conversion, increased hetero acids;
comparative example 3 demonstrates that ventilation is required to be controlled in the range of 90 to 120 LPM.
Comparative example 4 (comparative example 4)
Based on example 4, the pH and temperature control ranges in step 3 were further reduced or increased, resulting in the following table 8:
TABLE 8 different temperatures and pH
Sequence number | Temperature (DEG C) | pH | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 28 | 7.1 | 8.9 | 38.70 | 0.4 |
2 | 34 | 7.1 | 5.1 | 22.17 | 0.5 |
3 | 31 | 6.9 | 8.5 | 36.96 | 0.5 |
4 | 31 | 7.4 | 9.1 | 39.57 | 0.4 |
From the data of the 4 groups, the fermentation temperature and the pH can influence the fermentation acid production and the sugar acid ratio, but the mixed acid has no influence;
1. As seen from the data set 2, the fermentation temperature was lower or higher than the range of example 4, and the acid and sugar acid conversion began to decrease, especially as the fermentation temperature increased to 34 ℃ and the acid production was greatly decreased;
3. the acid production of the producing bacteria is adversely affected at pH6.9 and 7.4, but the acid is not increased as a result of the 4 sets of experimental data;
in summary, the fermentation temperature and pH are controlled to be 29-33 ℃ and 7.0-7.3 respectively.
Comparative example 5 (comparative example 5)
Based on example 5, the residual sugar control range in step 3 was further reduced or increased, resulting in the following table 9:
TABLE 9 different residual sugar concentrations
Sequence number | Residual sugar% | Acid production wt% | Sugar acid ratio% | Hetero acid wt% |
1 | 0.2 | 8.2 | 35.65 | 0.4 |
2 | 0.4 | 9.5 | 41.30 | 0.4 |
3 | 1.6 | 9.3 | 40.43 | 0.8 |
4 | 2 | 8.1 | 35.22 | 0.9 |
From the above 4 sets of data, both acid production and sugar acid conversion were at lower levels than in example 5, with lower acid and sugar acid ratios but no increase in the hetero acids when the residual sugar was below 0.5 wt%; when the residual sugar is higher than 1.5wt%, the acid production and sugar acid ratio is reduced, and the mixed acid starts to rise slightly, presumably mainly because of more residual sugar, the sugar metabolic process is changed, and the mixed acid is increased slightly;
in summary, the residual sugar is required to be controlled within the range of 0.5 to 1.5wt%, which is a suitable condition.
Comparative example 6
Based on example 1, the fermentation strain was replaced with Corynebacterium glutamicum CICC No.20160. The results showed that arginine production was reduced to 3.5wt%, sugar acid conversion was reduced to 15.5 wt% and the hetero acid content was increased to 1.50wt%. By comparison experiments, the following conclusions can be drawn:
Influence of strain selection on arginine fermentation process: in this experiment, it was found that when Corynebacterium glutamicum CICCNo.20160 was used as the fermentation strain, the arginine yield and the sugar acid conversion rate were significantly lower than those of Corynebacterium glutamicum IBBZ-01, probably because of the metabolic differences between the different strains, resulting in different efficiencies in arginine production.
Relationship between heteroacid formation and strain: in this experiment, it was also observed that when Corynebacterium glutamicum CICCNo.20160 was used, the content of hetero acids was higher than when Corynebacterium glutamicum IBBZ-01 was used, probably because the amount of by-products produced during metabolism was different from strain to strain, thus affecting the formation of hetero acids.
From the above, by the experimental data of comparative example 6, it can be concluded that: the selection of a proper strain is of great significance for improving the arginine fermentation efficiency. Corynebacterium glutamicum IBBZ-01 shows better performance in terms of arginine yield, sugar acid conversion and reduction of the formation of hetero acids than Corynebacterium glutamicum CICC No. 20160. Therefore, in practical operation, corynebacterium glutamicum IBBZ-01 should be preferred for the fermentative production of arginine.
The foregoing is a further description of the invention in connection with specific preferred embodiments thereof, and is not intended to limit the practice of the invention to such description. It is intended that all such variations and modifications as would be included within the scope of the invention are within the scope of the following claims.
Claims (10)
1. A corynebacterium glutamicum mutant is characterized in that the mutant is corynebacterium glutamicum IBBZ-01 (Corynebacterium glutamicum) and has a preservation number of CCTCC NO: M2022765.
2. A microbial agent comprising the mutant strain of claim 1, comprising: corynebacterium glutamicum IBBZ-01
The flora of (Corynebacterium glutamicum), and/or a culture thereof, and/or an extract thereof.
3. Use of the mutant strain of claim 1 in fermentation of L-arginine.
4. A use according to claim 3, characterized in that: comprising fermentation of L-arginine using Corynebacterium glutamicum IBBZ-01 (Corynebacterium glutamicum).
5. The use according to claim 4, characterized in that: the L-arginine fermentation method comprises the step of controlling the concentration of CO 2 in fermentation tail gas in stages according to the condition of the strain concentration OD 562.
6. The use according to claim 5, characterized in that: the method comprises the following steps:
(1) In the fermentation process, when the concentration OD 562 of the thallus is 10-20, the concentration of CO 2 is controlled to be 0.5-1.5%;
(2) When the strain concentration OD 562 is 20-30, controlling the concentration of CO 2 to be 2.0-3.5%;
(3) In the fermentation process, if the residual sugar is reduced to 0.5-1.5%, feeding a feed supplement sugar solution, wherein the residual sugar is controlled to be 0.5-1.5%;
(4) When the concentration OD 562 of the thalli is 30-40, controlling the concentration of CO 2 to be 4.0-5.0%;
(5) When the concentration OD 562 of the fermentation liquid to be detected is larger than 40, the concentration of CO 2 is controlled to be 5.5-6.5%.
7. The use according to claim 6, characterized in that: the feed supplement sugar solution is glucose solution with the weight percent of 50-80.
8. The use according to claim 6, characterized in that: the concentration range of CO 2 in the step (1) is 0.8-1.2%, the concentration range of CO 2 in the step (2) is 2.5-3.0%, the concentration range of CO 2 in the step (4) is 4.3-4.7%, and the concentration range of CO 2 in the step (5) is 5.8-6.2%.
9. The use according to claim 6, characterized in that: the fermentation condition is controlled at the initial stage of the fermentation process in the step (1): ventilation is 90-120 LPM, temperature is 29-33 ℃, pH is 7.0-7.3.
10. The use according to claim 6, characterized in that: the fermentation initial medium in the step (1) is as follows: 6 to 8 weight percent of glucose, 1.0 to 1.3 weight percent of corn steep liquor dry powder, 2.0 to 2.4 weight percent of molasses, 0.01 to 0.05 weight percent of yeast powder, 0.3 to 0.5 weight percent of ammonium sulfate and 0.05 to 0.07 weight percent of KH 2PO40.1~0.13wt%,MgSO4·7H2 O.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410043166.5A CN117903983A (en) | 2024-01-11 | 2024-01-11 | Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410043166.5A CN117903983A (en) | 2024-01-11 | 2024-01-11 | Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117903983A true CN117903983A (en) | 2024-04-19 |
Family
ID=90690494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410043166.5A Pending CN117903983A (en) | 2024-01-11 | 2024-01-11 | Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117903983A (en) |
-
2024
- 2024-01-11 CN CN202410043166.5A patent/CN117903983A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102154160B (en) | Strain capable of producing L-arginine and method for producing L-arginine by same | |
CN105368766B (en) | One plant of method for producing the genetic engineering bacterium of pentanediamine and its preparing pentanediamine | |
CN109082448B (en) | Escherichia coli and application thereof in fermentation production of 1, 5-pentanediamine | |
CN104404097A (en) | Fermentation production method of high-yield glutamine | |
JP4919400B2 (en) | Process for producing 5-aminolevulinic acid | |
CN112831437B (en) | Bacillus subtilis and fermentation method for high yield of indoleacetic acid and high spore formation rate | |
CN110656065B (en) | Streptomyces for producing epsilon-polylysine and application thereof | |
CN1982467B (en) | Production of glutamic acid based on pII feedback supplement | |
CN116121135B (en) | Corynebacterium glutamicum mutant strain and application thereof in L-isoleucine fermentation | |
CN110468167B (en) | Method for producing 1, 5-pentanediamine by fermentation | |
CN117903983A (en) | Corynebacterium glutamicum mutant strain, microbial inoculum thereof and application of corynebacterium glutamicum mutant strain in L-arginine fermentation | |
CN112725201B (en) | Liquid submerged fermentation method of pichia pastoris for producing acid protease | |
CN112852896A (en) | Fermentation production method of L-arginine | |
JP3074781B2 (en) | Production method of L-lysine by fermentation method | |
CN111172212A (en) | Fermentation method of high-content polyglutamic acid | |
CN114875090B (en) | Method for producing lysine and application thereof | |
JP2004194551A (en) | Method for low-temperature culture of bacterium | |
CN114045235B (en) | Method for producing single-cell protein and fermentable sugar by using methanotrophic bacteria | |
CN110964670B (en) | Escherichia coli capable of producing L-lysine and application thereof | |
EP2287324A2 (en) | Fermentation processes with low concentrations of carbon- and nitrogen-containing nutrients | |
CN112662609B (en) | Fermentation medium for increasing yield of beta-alanine and application method | |
CN114807259B (en) | Seed culture medium and fermentation culture medium for producing glutamic acid by fermentation | |
CN112694991B (en) | Strain for producing vitamin B12 and application thereof | |
CN101321860A (en) | Fermentation process for preparing L-lysine | |
TW202302836A (en) | Medium for culturing methylobacillus and culture method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination |